Trial intelligence / Profile preview

Triamcinolone for Diabetic Macular Edema during Cataract Surgery

NCT00849537Phase 2Unknown

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Apr 2008
Primary completion
Apr 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of triamcinolone in diabetic macular edema (DME), diabetic retinopathy (DR), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.

02

Drugs

triamcinolone
03

Conditions

diabetic macular edema (DME)diabetic retinopathy (DR)

Beyond the preview

Go deeper on NCT00849537.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00849537.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call